Wang G, Zhao K, Han J, Hu Z, et al. Safety and Immunogenicity of a Bivalent SARS-CoV-2 Recombinant Protein Vaccine, SCTV01C in Unvaccinated Adults: A Randomized, Double-blinded, Placebo-controlled, Phase I Clinical Trial. J Infect 2022 Nov 17:S0163-4453(22)00649-1. doi: 10.1016/j.jinf.2022.
PMID: 36403700